nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—SLC22A7—Fluorouracil—pancreatic cancer	0.0607	0.076	CbGbCtD
Erythromycin—ABCC1—Epirubicin—pancreatic cancer	0.0511	0.064	CbGbCtD
Erythromycin—ABCC1—Irinotecan—pancreatic cancer	0.0497	0.0622	CbGbCtD
Erythromycin—SLC22A7—Docetaxel—pancreatic cancer	0.0464	0.0581	CbGbCtD
Erythromycin—ABCC1—Docetaxel—pancreatic cancer	0.0364	0.0456	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.032	0.04	CbGbCtD
Erythromycin—CYP3A7—Tamoxifen—pancreatic cancer	0.032	0.04	CbGbCtD
Erythromycin—CYP2B6—Tamoxifen—pancreatic cancer	0.0304	0.0381	CbGbCtD
Erythromycin—ABCC1—Doxorubicin—pancreatic cancer	0.0271	0.034	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0246	0.0308	CbGbCtD
Erythromycin—CYP3A7—Irinotecan—pancreatic cancer	0.0246	0.0308	CbGbCtD
Erythromycin—CYP3A5—Tamoxifen—pancreatic cancer	0.024	0.03	CbGbCtD
Erythromycin—CYP2B6—Irinotecan—pancreatic cancer	0.0234	0.0293	CbGbCtD
Erythromycin—CYP1A2—Dacarbazine—pancreatic cancer	0.0224	0.0281	CbGbCtD
Erythromycin—CYP3A5—Erlotinib—pancreatic cancer	0.0204	0.0255	CbGbCtD
Erythromycin—CYP3A5—Irinotecan—pancreatic cancer	0.0184	0.0231	CbGbCtD
Erythromycin—CYP3A7—Docetaxel—pancreatic cancer	0.018	0.0225	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.018	0.0225	CbGbCtD
Erythromycin—CYP3A7—Sunitinib—pancreatic cancer	0.0179	0.0224	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0179	0.0224	CbGbCtD
Erythromycin—CYP1A2—Tamoxifen—pancreatic cancer	0.0179	0.0224	CbGbCtD
Erythromycin—ABCB1—Tamoxifen—pancreatic cancer	0.0156	0.0196	CbGbCtD
Erythromycin—CYP1A2—Erlotinib—pancreatic cancer	0.0152	0.019	CbGbCtD
Erythromycin—CYP3A5—Docetaxel—pancreatic cancer	0.0135	0.0169	CbGbCtD
Erythromycin—ABCB1—Gemcitabine—pancreatic cancer	0.0134	0.0168	CbGbCtD
Erythromycin—CYP3A5—Sunitinib—pancreatic cancer	0.0134	0.0168	CbGbCtD
Erythromycin—ABCB1—Erlotinib—pancreatic cancer	0.0133	0.0166	CbGbCtD
Erythromycin—CYP1A2—Fluorouracil—pancreatic cancer	0.0132	0.0165	CbGbCtD
Erythromycin—CYP2B6—Doxorubicin—pancreatic cancer	0.0128	0.016	CbGbCtD
Erythromycin—ABCB1—Irinotecan—pancreatic cancer	0.012	0.015	CbGbCtD
Erythromycin—CYP3A4—Tamoxifen—pancreatic cancer	0.00935	0.0117	CbGbCtD
Erythromycin—ABCB1—Docetaxel—pancreatic cancer	0.00878	0.011	CbGbCtD
Erythromycin—ABCB1—Sunitinib—pancreatic cancer	0.00874	0.011	CbGbCtD
Erythromycin—CYP3A4—Erlotinib—pancreatic cancer	0.00795	0.00996	CbGbCtD
Erythromycin—CYP3A4—Irinotecan—pancreatic cancer	0.00718	0.009	CbGbCtD
Erythromycin—ABCB1—Doxorubicin—pancreatic cancer	0.00655	0.0082	CbGbCtD
Erythromycin—CYP3A4—Docetaxel—pancreatic cancer	0.00526	0.00659	CbGbCtD
Erythromycin—CYP3A4—Sunitinib—pancreatic cancer	0.00524	0.00656	CbGbCtD
Erythromycin—CYP3A4—Doxorubicin—pancreatic cancer	0.00392	0.00491	CbGbCtD
Erythromycin—Sensitisation—Doxorubicin—pancreatic cancer	0.00108	0.0093	CcSEcCtD
Erythromycin—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.00105	0.00906	CcSEcCtD
Erythromycin—Skin exfoliation—Sunitinib—pancreatic cancer	0.00103	0.00892	CcSEcCtD
Erythromycin—Eruption—Docetaxel—pancreatic cancer	0.001	0.00865	CcSEcCtD
Erythromycin—Eye irritation—Fluorouracil—pancreatic cancer	0.001	0.00863	CcSEcCtD
Erythromycin—Injury—Tamoxifen—pancreatic cancer	0.000998	0.00862	CcSEcCtD
Erythromycin—Tenderness—Gemcitabine—pancreatic cancer	0.000995	0.00859	CcSEcCtD
Erythromycin—Tenderness—Fluorouracil—pancreatic cancer	0.000978	0.00845	CcSEcCtD
Erythromycin—Redness—Docetaxel—pancreatic cancer	0.000913	0.00788	CcSEcCtD
Erythromycin—Hearing impaired—Gemcitabine—pancreatic cancer	0.000912	0.00788	CcSEcCtD
Erythromycin—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.000899	0.00776	CcSEcCtD
Erythromycin—Burning sensation—Docetaxel—pancreatic cancer	0.000887	0.00766	CcSEcCtD
Erythromycin—Liver function test abnormal—Tamoxifen—pancreatic cancer	0.000847	0.00731	CcSEcCtD
Erythromycin—Skin exfoliation—Gemcitabine—pancreatic cancer	0.000829	0.00716	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.000817	0.00706	CcSEcCtD
Erythromycin—Hepatotoxicity—Docetaxel—pancreatic cancer	0.000798	0.00689	CcSEcCtD
Erythromycin—Pancreatitis—Tamoxifen—pancreatic cancer	0.000777	0.00671	CcSEcCtD
Erythromycin—Pancreatitis—Erlotinib—pancreatic cancer	0.000769	0.00664	CcSEcCtD
Erythromycin—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.00076	0.00656	CcSEcCtD
Erythromycin—Liver function test abnormal—Sunitinib—pancreatic cancer	0.000725	0.00626	CcSEcCtD
Erythromycin—Eye irritation—Docetaxel—pancreatic cancer	0.000722	0.00623	CcSEcCtD
Erythromycin—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.000721	0.00623	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.000707	0.00611	CcSEcCtD
Erythromycin—Deafness—Gemcitabine—pancreatic cancer	0.000705	0.00608	CcSEcCtD
Erythromycin—Injury—Irinotecan—pancreatic cancer	0.000704	0.00608	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.000701	0.00605	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.000693	0.00599	CcSEcCtD
Erythromycin—Eruption—Epirubicin—pancreatic cancer	0.000676	0.00583	CcSEcCtD
Erythromycin—Pancreatitis—Sunitinib—pancreatic cancer	0.000666	0.00575	CcSEcCtD
Erythromycin—Abdominal discomfort—Sunitinib—pancreatic cancer	0.000651	0.00562	CcSEcCtD
Erythromycin—Hearing impaired—Docetaxel—pancreatic cancer	0.000647	0.00559	CcSEcCtD
Erythromycin—Hepatitis—Tamoxifen—pancreatic cancer	0.000634	0.00548	CcSEcCtD
Erythromycin—Hepatitis—Erlotinib—pancreatic cancer	0.000628	0.00542	CcSEcCtD
Erythromycin—Eruption—Doxorubicin—pancreatic cancer	0.000625	0.0054	CcSEcCtD
Erythromycin—Redness—Epirubicin—pancreatic cancer	0.000616	0.00532	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.0006	0.00518	CcSEcCtD
Erythromycin—Erythema multiforme—Tamoxifen—pancreatic cancer	0.0006	0.00518	CcSEcCtD
Erythromycin—Burning sensation—Epirubicin—pancreatic cancer	0.000598	0.00517	CcSEcCtD
Erythromycin—Erythema multiforme—Erlotinib—pancreatic cancer	0.000594	0.00513	CcSEcCtD
Erythromycin—Irritability—Fluorouracil—pancreatic cancer	0.000591	0.00511	CcSEcCtD
Erythromycin—Skin exfoliation—Docetaxel—pancreatic cancer	0.000588	0.00508	CcSEcCtD
Erythromycin—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.000582	0.00503	CcSEcCtD
Erythromycin—Redness—Doxorubicin—pancreatic cancer	0.00057	0.00492	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.000568	0.0049	CcSEcCtD
Erythromycin—Arrhythmia—Tamoxifen—pancreatic cancer	0.000567	0.00489	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.000561	0.00485	CcSEcCtD
Erythromycin—Arrhythmia—Erlotinib—pancreatic cancer	0.000561	0.00484	CcSEcCtD
Erythromycin—Burning sensation—Doxorubicin—pancreatic cancer	0.000553	0.00478	CcSEcCtD
Erythromycin—Erythema—Tamoxifen—pancreatic cancer	0.000552	0.00477	CcSEcCtD
Erythromycin—Pancreatitis—Irinotecan—pancreatic cancer	0.000548	0.00473	CcSEcCtD
Erythromycin—Erythema—Erlotinib—pancreatic cancer	0.000546	0.00472	CcSEcCtD
Erythromycin—Hepatitis—Sunitinib—pancreatic cancer	0.000543	0.00469	CcSEcCtD
Erythromycin—Dysgeusia—Tamoxifen—pancreatic cancer	0.000541	0.00467	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.00052	0.00449	CcSEcCtD
Erythromycin—Erythema multiforme—Sunitinib—pancreatic cancer	0.000514	0.00444	CcSEcCtD
Erythromycin—Deafness—Docetaxel—pancreatic cancer	0.0005	0.00432	CcSEcCtD
Erythromycin—Jaundice—Irinotecan—pancreatic cancer	0.000486	0.0042	CcSEcCtD
Erythromycin—Arrhythmia—Sunitinib—pancreatic cancer	0.000485	0.00419	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000482	0.00416	CcSEcCtD
Erythromycin—Erythema—Sunitinib—pancreatic cancer	0.000473	0.00409	CcSEcCtD
Erythromycin—Chest pain—Tamoxifen—pancreatic cancer	0.00047	0.00406	CcSEcCtD
Erythromycin—Chest pain—Erlotinib—pancreatic cancer	0.000465	0.00402	CcSEcCtD
Erythromycin—Discomfort—Tamoxifen—pancreatic cancer	0.000465	0.00401	CcSEcCtD
Erythromycin—Dysgeusia—Sunitinib—pancreatic cancer	0.000463	0.004	CcSEcCtD
Erythromycin—Anorexia—Tamoxifen—pancreatic cancer	0.00043	0.00371	CcSEcCtD
Erythromycin—Anorexia—Erlotinib—pancreatic cancer	0.000425	0.00367	CcSEcCtD
Erythromycin—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.000416	0.00359	CcSEcCtD
Erythromycin—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000413	0.00357	CcSEcCtD
Erythromycin—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000412	0.00356	CcSEcCtD
Erythromycin—Convulsion—Sunitinib—pancreatic cancer	0.00041	0.00354	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000403	0.00348	CcSEcCtD
Erythromycin—Chest pain—Sunitinib—pancreatic cancer	0.000403	0.00348	CcSEcCtD
Erythromycin—Arrhythmia—Irinotecan—pancreatic cancer	0.0004	0.00345	CcSEcCtD
Erythromycin—Skin exfoliation—Epirubicin—pancreatic cancer	0.000397	0.00343	CcSEcCtD
Erythromycin—Decreased appetite—Tamoxifen—pancreatic cancer	0.000392	0.00338	CcSEcCtD
Erythromycin—Arrhythmia—Gemcitabine—pancreatic cancer	0.00039	0.00336	CcSEcCtD
Erythromycin—Decreased appetite—Erlotinib—pancreatic cancer	0.000388	0.00335	CcSEcCtD
Erythromycin—Pain—Tamoxifen—pancreatic cancer	0.000385	0.00333	CcSEcCtD
Erythromycin—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.000385	0.00332	CcSEcCtD
Erythromycin—Arrhythmia—Fluorouracil—pancreatic cancer	0.000383	0.00331	CcSEcCtD
Erythromycin—Pain—Erlotinib—pancreatic cancer	0.000381	0.00329	CcSEcCtD
Erythromycin—Erythema—Gemcitabine—pancreatic cancer	0.00038	0.00328	CcSEcCtD
Erythromycin—Erythema—Fluorouracil—pancreatic cancer	0.000373	0.00322	CcSEcCtD
Erythromycin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000369	0.00318	CcSEcCtD
Erythromycin—Anorexia—Sunitinib—pancreatic cancer	0.000368	0.00318	CcSEcCtD
Erythromycin—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000367	0.00317	CcSEcCtD
Erythromycin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000365	0.00315	CcSEcCtD
Erythromycin—Urticaria—Tamoxifen—pancreatic cancer	0.000358	0.00309	CcSEcCtD
Erythromycin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000356	0.00308	CcSEcCtD
Erythromycin—Abdominal pain—Erlotinib—pancreatic cancer	0.000353	0.00304	CcSEcCtD
Erythromycin—Vertigo—Irinotecan—pancreatic cancer	0.00035	0.00302	CcSEcCtD
Erythromycin—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000345	0.00298	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000342	0.00295	CcSEcCtD
Erythromycin—Jaundice—Docetaxel—pancreatic cancer	0.000336	0.0029	CcSEcCtD
Erythromycin—Decreased appetite—Sunitinib—pancreatic cancer	0.000336	0.0029	CcSEcCtD
Erythromycin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000332	0.00287	CcSEcCtD
Erythromycin—Pain—Sunitinib—pancreatic cancer	0.00033	0.00285	CcSEcCtD
Erythromycin—Discomfort—Irinotecan—pancreatic cancer	0.000328	0.00283	CcSEcCtD
Erythromycin—Convulsion—Fluorouracil—pancreatic cancer	0.000323	0.00279	CcSEcCtD
Erythromycin—Chest pain—Gemcitabine—pancreatic cancer	0.000323	0.00279	CcSEcCtD
Erythromycin—Confusional state—Irinotecan—pancreatic cancer	0.000321	0.00277	CcSEcCtD
Erythromycin—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000319	0.00276	CcSEcCtD
Erythromycin—Discomfort—Gemcitabine—pancreatic cancer	0.000319	0.00276	CcSEcCtD
Erythromycin—Pruritus—Tamoxifen—pancreatic cancer	0.000319	0.00275	CcSEcCtD
Erythromycin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000318	0.00275	CcSEcCtD
Erythromycin—Chest pain—Fluorouracil—pancreatic cancer	0.000318	0.00274	CcSEcCtD
Erythromycin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000316	0.00273	CcSEcCtD
Erythromycin—Pruritus—Erlotinib—pancreatic cancer	0.000316	0.00272	CcSEcCtD
Erythromycin—Discomfort—Fluorouracil—pancreatic cancer	0.000314	0.00271	CcSEcCtD
Erythromycin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00031	0.00268	CcSEcCtD
Erythromycin—Hepatitis—Docetaxel—pancreatic cancer	0.000309	0.00267	CcSEcCtD
Erythromycin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000308	0.00266	CcSEcCtD
Erythromycin—Confusional state—Fluorouracil—pancreatic cancer	0.000307	0.00265	CcSEcCtD
Erythromycin—Abdominal pain—Sunitinib—pancreatic cancer	0.000305	0.00264	CcSEcCtD
Erythromycin—Diarrhoea—Erlotinib—pancreatic cancer	0.000305	0.00264	CcSEcCtD
Erythromycin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000305	0.00263	CcSEcCtD
Erythromycin—Anorexia—Irinotecan—pancreatic cancer	0.000303	0.00262	CcSEcCtD
Erythromycin—Dizziness—Tamoxifen—pancreatic cancer	0.000298	0.00257	CcSEcCtD
Erythromycin—Anorexia—Gemcitabine—pancreatic cancer	0.000295	0.00255	CcSEcCtD
Erythromycin—Dizziness—Erlotinib—pancreatic cancer	0.000295	0.00255	CcSEcCtD
Erythromycin—Erythema multiforme—Docetaxel—pancreatic cancer	0.000293	0.00253	CcSEcCtD
Erythromycin—Anorexia—Fluorouracil—pancreatic cancer	0.00029	0.00251	CcSEcCtD
Erythromycin—Vomiting—Tamoxifen—pancreatic cancer	0.000287	0.00247	CcSEcCtD
Erythromycin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000284	0.00246	CcSEcCtD
Erythromycin—Rash—Tamoxifen—pancreatic cancer	0.000284	0.00245	CcSEcCtD
Erythromycin—Vomiting—Erlotinib—pancreatic cancer	0.000284	0.00245	CcSEcCtD
Erythromycin—Rash—Erlotinib—pancreatic cancer	0.000281	0.00243	CcSEcCtD
Erythromycin—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000279	0.00241	CcSEcCtD
Erythromycin—Decreased appetite—Irinotecan—pancreatic cancer	0.000276	0.00239	CcSEcCtD
Erythromycin—Arrhythmia—Docetaxel—pancreatic cancer	0.000276	0.00239	CcSEcCtD
Erythromycin—Pruritus—Sunitinib—pancreatic cancer	0.000273	0.00236	CcSEcCtD
Erythromycin—Pain—Irinotecan—pancreatic cancer	0.000272	0.00235	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000272	0.00235	CcSEcCtD
Erythromycin—Erythema—Docetaxel—pancreatic cancer	0.000269	0.00233	CcSEcCtD
Erythromycin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000269	0.00233	CcSEcCtD
Erythromycin—Nausea—Tamoxifen—pancreatic cancer	0.000268	0.00231	CcSEcCtD
Erythromycin—Pain—Gemcitabine—pancreatic cancer	0.000265	0.00229	CcSEcCtD
Erythromycin—Nausea—Erlotinib—pancreatic cancer	0.000265	0.00229	CcSEcCtD
Erythromycin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000265	0.00229	CcSEcCtD
Erythromycin—Diarrhoea—Sunitinib—pancreatic cancer	0.000264	0.00228	CcSEcCtD
Erythromycin—Dysgeusia—Docetaxel—pancreatic cancer	0.000264	0.00228	CcSEcCtD
Erythromycin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000262	0.00226	CcSEcCtD
Erythromycin—Pain—Fluorouracil—pancreatic cancer	0.00026	0.00225	CcSEcCtD
Erythromycin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00026	0.00225	CcSEcCtD
Erythromycin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000258	0.00223	CcSEcCtD
Erythromycin—Pancreatitis—Epirubicin—pancreatic cancer	0.000256	0.00221	CcSEcCtD
Erythromycin—Dizziness—Sunitinib—pancreatic cancer	0.000255	0.0022	CcSEcCtD
Erythromycin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000255	0.0022	CcSEcCtD
Erythromycin—Abdominal pain—Irinotecan—pancreatic cancer	0.000251	0.00217	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000251	0.00217	CcSEcCtD
Erythromycin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000251	0.00217	CcSEcCtD
Erythromycin—Vomiting—Sunitinib—pancreatic cancer	0.000245	0.00212	CcSEcCtD
Erythromycin—Rash—Sunitinib—pancreatic cancer	0.000243	0.0021	CcSEcCtD
Erythromycin—Urticaria—Fluorouracil—pancreatic cancer	0.000242	0.00209	CcSEcCtD
Erythromycin—Palpitations—Docetaxel—pancreatic cancer	0.000238	0.00206	CcSEcCtD
Erythromycin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000237	0.00204	CcSEcCtD
Erythromycin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000234	0.00202	CcSEcCtD
Erythromycin—Convulsion—Docetaxel—pancreatic cancer	0.000233	0.00202	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00023	0.00199	CcSEcCtD
Erythromycin—Chest pain—Docetaxel—pancreatic cancer	0.000229	0.00198	CcSEcCtD
Erythromycin—Nausea—Sunitinib—pancreatic cancer	0.000229	0.00198	CcSEcCtD
Erythromycin—Jaundice—Epirubicin—pancreatic cancer	0.000227	0.00196	CcSEcCtD
Erythromycin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000224	0.00194	CcSEcCtD
Erythromycin—Confusional state—Docetaxel—pancreatic cancer	0.000222	0.00191	CcSEcCtD
Erythromycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00022	0.0019	CcSEcCtD
Erythromycin—Pruritus—Gemcitabine—pancreatic cancer	0.000219	0.00189	CcSEcCtD
Erythromycin—Diarrhoea—Irinotecan—pancreatic cancer	0.000218	0.00188	CcSEcCtD
Erythromycin—Pruritus—Fluorouracil—pancreatic cancer	0.000215	0.00186	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000213	0.00184	CcSEcCtD
Erythromycin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000212	0.00183	CcSEcCtD
Erythromycin—Dizziness—Irinotecan—pancreatic cancer	0.00021	0.00182	CcSEcCtD
Erythromycin—Jaundice—Doxorubicin—pancreatic cancer	0.00021	0.00181	CcSEcCtD
Erythromycin—Anorexia—Docetaxel—pancreatic cancer	0.00021	0.00181	CcSEcCtD
Erythromycin—Hepatitis—Epirubicin—pancreatic cancer	0.000209	0.0018	CcSEcCtD
Erythromycin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000208	0.0018	CcSEcCtD
Erythromycin—Vomiting—Irinotecan—pancreatic cancer	0.000202	0.00175	CcSEcCtD
Erythromycin—Dizziness—Fluorouracil—pancreatic cancer	0.000201	0.00174	CcSEcCtD
Erythromycin—Rash—Irinotecan—pancreatic cancer	0.000201	0.00173	CcSEcCtD
Erythromycin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000197	0.0017	CcSEcCtD
Erythromycin—Vomiting—Gemcitabine—pancreatic cancer	0.000197	0.0017	CcSEcCtD
Erythromycin—Rash—Gemcitabine—pancreatic cancer	0.000195	0.00169	CcSEcCtD
Erythromycin—Tinnitus—Epirubicin—pancreatic cancer	0.000195	0.00168	CcSEcCtD
Erythromycin—Vomiting—Fluorouracil—pancreatic cancer	0.000194	0.00167	CcSEcCtD
Erythromycin—Hepatitis—Doxorubicin—pancreatic cancer	0.000193	0.00167	CcSEcCtD
Erythromycin—Rash—Fluorouracil—pancreatic cancer	0.000192	0.00166	CcSEcCtD
Erythromycin—Decreased appetite—Docetaxel—pancreatic cancer	0.000191	0.00165	CcSEcCtD
Erythromycin—Nausea—Irinotecan—pancreatic cancer	0.000189	0.00163	CcSEcCtD
Erythromycin—Pain—Docetaxel—pancreatic cancer	0.000188	0.00162	CcSEcCtD
Erythromycin—Arrhythmia—Epirubicin—pancreatic cancer	0.000186	0.00161	CcSEcCtD
Erythromycin—Nausea—Gemcitabine—pancreatic cancer	0.000184	0.00159	CcSEcCtD
Erythromycin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000183	0.00158	CcSEcCtD
Erythromycin—Erythema—Epirubicin—pancreatic cancer	0.000182	0.00157	CcSEcCtD
Erythromycin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000181	0.00156	CcSEcCtD
Erythromycin—Nausea—Fluorouracil—pancreatic cancer	0.000181	0.00156	CcSEcCtD
Erythromycin—Tinnitus—Doxorubicin—pancreatic cancer	0.00018	0.00155	CcSEcCtD
Erythromycin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00018	0.00155	CcSEcCtD
Erythromycin—Dysgeusia—Epirubicin—pancreatic cancer	0.000178	0.00154	CcSEcCtD
Erythromycin—Abdominal pain—Docetaxel—pancreatic cancer	0.000174	0.0015	CcSEcCtD
Erythromycin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000173	0.00149	CcSEcCtD
Erythromycin—Erythema—Doxorubicin—pancreatic cancer	0.000168	0.00145	CcSEcCtD
Erythromycin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000165	0.00142	CcSEcCtD
Erythromycin—Vertigo—Epirubicin—pancreatic cancer	0.000163	0.00141	CcSEcCtD
Erythromycin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000162	0.0014	CcSEcCtD
Erythromycin—Palpitations—Epirubicin—pancreatic cancer	0.000161	0.00139	CcSEcCtD
Erythromycin—Convulsion—Epirubicin—pancreatic cancer	0.000157	0.00136	CcSEcCtD
Erythromycin—Pruritus—Docetaxel—pancreatic cancer	0.000156	0.00134	CcSEcCtD
Erythromycin—Chest pain—Epirubicin—pancreatic cancer	0.000155	0.00134	CcSEcCtD
Erythromycin—Discomfort—Epirubicin—pancreatic cancer	0.000153	0.00132	CcSEcCtD
Erythromycin—Vertigo—Doxorubicin—pancreatic cancer	0.000151	0.0013	CcSEcCtD
Erythromycin—Diarrhoea—Docetaxel—pancreatic cancer	0.00015	0.0013	CcSEcCtD
Erythromycin—Confusional state—Epirubicin—pancreatic cancer	0.00015	0.00129	CcSEcCtD
Erythromycin—Palpitations—Doxorubicin—pancreatic cancer	0.000149	0.00128	CcSEcCtD
Erythromycin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000148	0.00128	CcSEcCtD
Erythromycin—Convulsion—Doxorubicin—pancreatic cancer	0.000146	0.00126	CcSEcCtD
Erythromycin—Dizziness—Docetaxel—pancreatic cancer	0.000145	0.00126	CcSEcCtD
Erythromycin—Chest pain—Doxorubicin—pancreatic cancer	0.000143	0.00124	CcSEcCtD
Erythromycin—Discomfort—Doxorubicin—pancreatic cancer	0.000141	0.00122	CcSEcCtD
Erythromycin—Anorexia—Epirubicin—pancreatic cancer	0.000141	0.00122	CcSEcCtD
Erythromycin—Vomiting—Docetaxel—pancreatic cancer	0.00014	0.00121	CcSEcCtD
Erythromycin—Rash—Docetaxel—pancreatic cancer	0.000139	0.0012	CcSEcCtD
Erythromycin—Confusional state—Doxorubicin—pancreatic cancer	0.000138	0.00119	CcSEcCtD
Erythromycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000137	0.00118	CcSEcCtD
Erythromycin—Anorexia—Doxorubicin—pancreatic cancer	0.000131	0.00113	CcSEcCtD
Erythromycin—Nausea—Docetaxel—pancreatic cancer	0.000131	0.00113	CcSEcCtD
Erythromycin—Decreased appetite—Epirubicin—pancreatic cancer	0.000129	0.00111	CcSEcCtD
Erythromycin—Pain—Epirubicin—pancreatic cancer	0.000127	0.0011	CcSEcCtD
Erythromycin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000122	0.00106	CcSEcCtD
Erythromycin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000121	0.00105	CcSEcCtD
Erythromycin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000119	0.00103	CcSEcCtD
Erythromycin—Urticaria—Epirubicin—pancreatic cancer	0.000118	0.00102	CcSEcCtD
Erythromycin—Pain—Doxorubicin—pancreatic cancer	0.000117	0.00101	CcSEcCtD
Erythromycin—Abdominal pain—Epirubicin—pancreatic cancer	0.000117	0.00101	CcSEcCtD
Erythromycin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000113	0.000976	CcSEcCtD
Erythromycin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000112	0.000969	CcSEcCtD
Erythromycin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000109	0.000943	CcSEcCtD
Erythromycin—Urticaria—Doxorubicin—pancreatic cancer	0.000109	0.000941	CcSEcCtD
Erythromycin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000108	0.000937	CcSEcCtD
Erythromycin—Pruritus—Epirubicin—pancreatic cancer	0.000105	0.000906	CcSEcCtD
Erythromycin—Diarrhoea—Epirubicin—pancreatic cancer	0.000101	0.000876	CcSEcCtD
Erythromycin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000101	0.000873	CcSEcCtD
Erythromycin—Dizziness—Epirubicin—pancreatic cancer	9.81e-05	0.000847	CcSEcCtD
Erythromycin—Pruritus—Doxorubicin—pancreatic cancer	9.71e-05	0.000838	CcSEcCtD
Erythromycin—Vomiting—Epirubicin—pancreatic cancer	9.43e-05	0.000814	CcSEcCtD
Erythromycin—Diarrhoea—Doxorubicin—pancreatic cancer	9.39e-05	0.000811	CcSEcCtD
Erythromycin—Rash—Epirubicin—pancreatic cancer	9.35e-05	0.000807	CcSEcCtD
Erythromycin—Dizziness—Doxorubicin—pancreatic cancer	9.07e-05	0.000783	CcSEcCtD
Erythromycin—Nausea—Epirubicin—pancreatic cancer	8.81e-05	0.000761	CcSEcCtD
Erythromycin—Vomiting—Doxorubicin—pancreatic cancer	8.72e-05	0.000753	CcSEcCtD
Erythromycin—Rash—Doxorubicin—pancreatic cancer	8.65e-05	0.000747	CcSEcCtD
Erythromycin—Nausea—Doxorubicin—pancreatic cancer	8.15e-05	0.000704	CcSEcCtD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	4.17e-05	0.000486	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	4.17e-05	0.000486	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	4.14e-05	0.000482	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL8—pancreatic cancer	4.08e-05	0.000475	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HRAS—pancreatic cancer	4.05e-05	0.000472	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HEY1—pancreatic cancer	3.98e-05	0.000464	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	3.96e-05	0.000461	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AKT1—pancreatic cancer	3.94e-05	0.000459	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CASP3—pancreatic cancer	3.9e-05	0.000455	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TYMP—pancreatic cancer	3.85e-05	0.000448	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ARG2—pancreatic cancer	3.84e-05	0.000447	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCND1—pancreatic cancer	3.8e-05	0.000443	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CTNNB1—pancreatic cancer	3.76e-05	0.000438	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MMP9—pancreatic cancer	3.69e-05	0.00043	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTEN—pancreatic cancer	3.67e-05	0.000427	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.63e-05	0.000423	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AKT1—pancreatic cancer	3.58e-05	0.000417	CbGpPWpGaD
Erythromycin—ABCC1—Disease—JAG2—pancreatic cancer	3.53e-05	0.000412	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.53e-05	0.000411	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.52e-05	0.00041	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MEN1—pancreatic cancer	3.48e-05	0.000406	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SLC2A2—pancreatic cancer	3.46e-05	0.000403	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	3.45e-05	0.000402	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SRC—pancreatic cancer	3.4e-05	0.000396	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—DPYD—pancreatic cancer	3.39e-05	0.000395	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.39e-05	0.000395	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.37e-05	0.000393	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TYMP—pancreatic cancer	3.36e-05	0.000391	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SHH—pancreatic cancer	3.32e-05	0.000387	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VEGFA—pancreatic cancer	3.31e-05	0.000386	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IAPP—pancreatic cancer	3.28e-05	0.000382	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT3—pancreatic cancer	3.28e-05	0.000382	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PRSS1—pancreatic cancer	3.28e-05	0.000382	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NRAS—pancreatic cancer	3.27e-05	0.000381	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.23e-05	0.000376	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	3.22e-05	0.000375	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PRSS1—pancreatic cancer	3.2e-05	0.000373	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.19e-05	0.000371	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.18e-05	0.00037	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HSPA1B—pancreatic cancer	3.15e-05	0.000367	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GLP1R—pancreatic cancer	3.1e-05	0.000361	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.07e-05	0.000358	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—DPYD—pancreatic cancer	3.05e-05	0.000356	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MYC—pancreatic cancer	3.05e-05	0.000355	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TGFB1—pancreatic cancer	3.04e-05	0.000354	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EGFR—pancreatic cancer	2.98e-05	0.000347	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.94e-05	0.000343	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.92e-05	0.00034	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SLC2A2—pancreatic cancer	2.9e-05	0.000337	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.87e-05	0.000334	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ARG2—pancreatic cancer	2.84e-05	0.000331	CbGpPWpGaD
Erythromycin—ABCC1—Disease—JAG1—pancreatic cancer	2.82e-05	0.000328	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KRAS—pancreatic cancer	2.82e-05	0.000328	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.8e-05	0.000326	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ARG2—pancreatic cancer	2.78e-05	0.000323	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.77e-05	0.000322	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GLP1R—pancreatic cancer	2.71e-05	0.000315	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD44—pancreatic cancer	2.68e-05	0.000312	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—DPYD—pancreatic cancer	2.66e-05	0.00031	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HSPA1A—pancreatic cancer	2.66e-05	0.00031	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PIK3CA—pancreatic cancer	2.59e-05	0.000301	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	2.53e-05	0.000294	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.52e-05	0.000294	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—pancreatic cancer	2.5e-05	0.000292	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CD44—pancreatic cancer	2.49e-05	0.00029	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TYMP—pancreatic cancer	2.48e-05	0.000289	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.48e-05	0.000289	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.44e-05	0.000284	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TYMP—pancreatic cancer	2.43e-05	0.000283	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.42e-05	0.000282	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.42e-05	0.000281	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRAS—pancreatic cancer	2.39e-05	0.000279	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GCG—pancreatic cancer	2.39e-05	0.000278	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.3e-05	0.000268	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—STK11—pancreatic cancer	2.25e-05	0.000262	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CD44—pancreatic cancer	2.24e-05	0.000261	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.24e-05	0.000261	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.22e-05	0.000258	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.2e-05	0.000256	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.18e-05	0.000253	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.16e-05	0.000252	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GCG—pancreatic cancer	2.15e-05	0.00025	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SMAD4—pancreatic cancer	2.11e-05	0.000246	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AKT1—pancreatic cancer	2.11e-05	0.000246	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.11e-05	0.000246	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ARG2—pancreatic cancer	2.09e-05	0.000244	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HES1—pancreatic cancer	2.06e-05	0.00024	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—STK11—pancreatic cancer	2.02e-05	0.000236	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.01e-05	0.000234	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2e-05	0.000233	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—DPYD—pancreatic cancer	1.97e-05	0.000229	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CD44—pancreatic cancer	1.96e-05	0.000228	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.96e-05	0.000228	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.95e-05	0.000227	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TYMS—pancreatic cancer	1.93e-05	0.000225	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.93e-05	0.000225	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.92e-05	0.000224	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.9e-05	0.000221	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GCG—pancreatic cancer	1.88e-05	0.000218	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	1.87e-05	0.000218	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TYMP—pancreatic cancer	1.83e-05	0.000213	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.83e-05	0.000213	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TERT—pancreatic cancer	1.81e-05	0.000211	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.8e-05	0.000209	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.79e-05	0.000209	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—STK11—pancreatic cancer	1.76e-05	0.000205	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.76e-05	0.000205	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TYMS—pancreatic cancer	1.74e-05	0.000203	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HIF1A—pancreatic cancer	1.73e-05	0.000202	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TSC2—pancreatic cancer	1.73e-05	0.000201	CbGpPWpGaD
Erythromycin—ABCC1—Disease—APOE—pancreatic cancer	1.69e-05	0.000197	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.67e-05	0.000195	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.67e-05	0.000195	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.66e-05	0.000193	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—APOE—pancreatic cancer	1.57e-05	0.000183	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOTCH1—pancreatic cancer	1.56e-05	0.000182	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.53e-05	0.000178	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TYMS—pancreatic cancer	1.52e-05	0.000177	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGF—pancreatic cancer	1.51e-05	0.000175	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.49e-05	0.000173	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.49e-05	0.000173	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.48e-05	0.000172	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.48e-05	0.000172	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.46e-05	0.00017	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—DPYD—pancreatic cancer	1.45e-05	0.000169	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CD44—pancreatic cancer	1.45e-05	0.000169	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.42e-05	0.000165	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—APOE—pancreatic cancer	1.41e-05	0.000165	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CD44—pancreatic cancer	1.41e-05	0.000165	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GCG—pancreatic cancer	1.39e-05	0.000162	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.38e-05	0.00016	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.37e-05	0.000159	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GCG—pancreatic cancer	1.36e-05	0.000158	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PIK3CD—pancreatic cancer	1.34e-05	0.000156	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.34e-05	0.000156	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—STK11—pancreatic cancer	1.3e-05	0.000152	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.29e-05	0.00015	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CG—pancreatic cancer	1.28e-05	0.000149	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000148	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.25e-05	0.000145	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.25e-05	0.000145	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—APOE—pancreatic cancer	1.23e-05	0.000144	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PPARG—pancreatic cancer	1.23e-05	0.000144	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.21e-05	0.00014	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.18e-05	0.000137	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PIK3CB—pancreatic cancer	1.17e-05	0.000136	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.16e-05	0.000135	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTGS2—pancreatic cancer	1.16e-05	0.000135	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.13e-05	0.000131	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CD—pancreatic cancer	1.12e-05	0.000131	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.12e-05	0.000131	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.11e-05	0.00013	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.1e-05	0.000128	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.1e-05	0.000128	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.09e-05	0.000127	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.09e-05	0.000127	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.08e-05	0.000125	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.07e-05	0.000125	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CD44—pancreatic cancer	1.07e-05	0.000124	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.05e-05	0.000122	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CTNNB1—pancreatic cancer	1.04e-05	0.000121	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GCG—pancreatic cancer	1.02e-05	0.000119	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTEN—pancreatic cancer	1.01e-05	0.000118	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	9.79e-06	0.000114	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CB—pancreatic cancer	9.78e-06	0.000114	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS2—pancreatic cancer	9.69e-06	0.000113	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—STK11—pancreatic cancer	9.62e-06	0.000112	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.57e-06	0.000111	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTEN—pancreatic cancer	9.39e-06	0.000109	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SRC—pancreatic cancer	9.36e-06	0.000109	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—APOE—pancreatic cancer	9.12e-06	0.000106	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.09e-06	0.000106	CbGpPWpGaD
Erythromycin—ABCC1—Disease—STAT3—pancreatic cancer	9.03e-06	0.000105	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NRAS—pancreatic cancer	9e-06	0.000105	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—DPYD—pancreatic cancer	8.95e-06	0.000104	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—APOE—pancreatic cancer	8.92e-06	0.000104	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	8.53e-06	9.94e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CD44—pancreatic cancer	8.52e-06	9.92e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.49e-06	9.89e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS2—pancreatic cancer	8.45e-06	9.85e-05	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTEN—pancreatic cancer	8.45e-06	9.85e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MYC—pancreatic cancer	8.39e-06	9.77e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TGFB1—pancreatic cancer	8.37e-06	9.75e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.34e-06	9.72e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TYMS—pancreatic cancer	8.27e-06	9.64e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.27e-06	9.63e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	8.23e-06	9.59e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—pancreatic cancer	8.2e-06	9.56e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GCG—pancreatic cancer	8.17e-06	9.51e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	8.05e-06	9.37e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PPARG—pancreatic cancer	7.95e-06	9.26e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PPARG—pancreatic cancer	7.77e-06	9.05e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—KRAS—pancreatic cancer	7.75e-06	9.03e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—STK11—pancreatic cancer	7.68e-06	8.94e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTEN—pancreatic cancer	7.37e-06	8.59e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	7.24e-06	8.43e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.21e-06	8.4e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PIK3CA—pancreatic cancer	7.12e-06	8.29e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	7.08e-06	8.24e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—APOE—pancreatic cancer	6.73e-06	7.84e-05	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	6.63e-06	7.72e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.61e-06	7.69e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HRAS—pancreatic cancer	6.59e-06	7.67e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CD44—pancreatic cancer	6.57e-06	7.66e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	6.31e-06	7.35e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GCG—pancreatic cancer	6.3e-06	7.34e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS2—pancreatic cancer	6.25e-06	7.28e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	6.17e-06	7.18e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS2—pancreatic cancer	6.11e-06	7.12e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.07e-06	7.07e-05	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CA—pancreatic cancer	5.96e-06	6.95e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—STK11—pancreatic cancer	5.93e-06	6.9e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PPARG—pancreatic cancer	5.86e-06	6.83e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKT1—pancreatic cancer	5.82e-06	6.77e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTEN—pancreatic cancer	5.45e-06	6.35e-05	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKT1—pancreatic cancer	5.41e-06	6.31e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—APOE—pancreatic cancer	5.37e-06	6.26e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.34e-06	6.22e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.33e-06	6.21e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	5.2e-06	6.06e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.1e-06	5.94e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.09e-06	5.92e-05	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKT1—pancreatic cancer	4.87e-06	5.67e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.85e-06	5.65e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.68e-06	5.45e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.65e-06	5.42e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.61e-06	5.37e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.26e-06	4.96e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKT1—pancreatic cancer	4.25e-06	4.95e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—APOE—pancreatic cancer	4.15e-06	4.83e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTEN—pancreatic cancer	4.02e-06	4.68e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	3.85e-06	4.48e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.76e-06	4.38e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.74e-06	4.36e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.71e-06	4.33e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.68e-06	4.29e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.61e-06	4.21e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.29e-06	3.83e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.21e-06	3.74e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKT1—pancreatic cancer	3.14e-06	3.66e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKT1—pancreatic cancer	3.07e-06	3.58e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.87e-06	3.34e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.84e-06	3.31e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.84e-06	3.3e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.48e-06	2.89e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKT1—pancreatic cancer	2.32e-06	2.7e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.26e-06	2.64e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.85e-06	2.15e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.75e-06	2.04e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.43e-06	1.66e-05	CbGpPWpGaD
